Clinical Trial VICCTHN1291


Early Diagnosis of Pulmonary Nodules Using a Plasma Proteomic Classifier

Principal Investigator(s)

Pierre Massion


  • Protocol No. VICCTHN1291
  • Open Date: 03/28/2013
  • Staging: NA
  • Age Group: Adults
  • Scope: National
  • Objective: Determine the positive predictive value (PPV) and negative predictive value (NPV) of the multi-protein classifier, e.g. lung nodule test (LNT), based on the observed study prevalence of NSCLC, for subjects with a lung nodule between 8 to 20 mm in size, except for those characterized as "pure ground glass opacity (GGO)" or "non-solid," i.e. having no solid component.
  • Disease Sites: Lung
  • Therapies: None Specified
  • Drugs: None Specified
  • Participating Institutions: Vanderbilt University
  • National Clinical Trial ID: NCT01752114
  • Secondary Protocol No: 1001-12



Learn More

You do not have JavaScript enabled. This site works better with JavaScript turned on.